Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
AgriFORCE (NASDAQ: AGRI) Reaffirms Bitcoin Treasury Strategy and Initiates Step Out of Operations Under Its Previously Announced LOI With BlueFlare Energy
-
Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results
-
Wag! Group Co. Announces Sale of Furscription to MWI Veterinary Supply Co.
-
Xsolis Launches AI Amplified, a New Podcast Hosted by Chief Medical Officer Dr. Heather Bassett, Spotlighting the Real-World Impact of AI in Healthcare
-
SharpLink Becomes World’s Largest Corporate Holder of ETH, Reaching 280,706 as of July 13, 2025; Raises Additional $413 Million From July 7-11, 2025
-
Australian Oilseeds Expands Market Reach Through Strategic Partnership to Accelerate Growth in Vietnam
-
Horizon Aircraft and ZeroAvia Announce Plans to Explore Hydrogen eVTOL Propulsion
-
Scoop Up FREE Ice Cream at Stop & Shop This Weekend to Celebrate National Ice Cream Day
-
J & J SNACK FOODS SCHEDULES FISCAL 2025 THIRD QUARTER EARNINGS CONFERENCE CALL AND WEBCAST
-
NANO Nuclear Appoints Vice Admiral Charles J. “Joe” Leidig, Jr. (Ret.) as Chairman of its Executive Advisory Board for Naval Nuclear Initiatives
-
Research: Consumer Mobile Frustration Is Rising – And It’s Costing Brands
-
Captivision, Inc. Announces Compliance with Nasdaq’s Market Value of Listed Securities and Minimum Bid Price Requirements
-
MOTHERS SELECT GRASSROOTS PROJECTS FOR GRANTS
-
Medera and University of Kansas Medical Center Announce First Patient Treated in Pioneering Gene Therapy Trial for Duchenne Muscular Dystrophy Associated Cardiomyopathy
-
Scoop Up FREE Ice Cream at Stop & Shop This Weekend to Celebrate National Ice Cream Day
-
Skyharbour’s Partner Company UraEx Resources Commences Summer 2025 Drilling Program at South Dufferin Uranium Project, Athabasca Basin, Saskatchewan
-
WillScot to Announce Second Quarter 2025 Results on July 31, 2025
-
Coralogix Introduces MCP Server to Help Customers Build Smarter AI Agents
-
Extendicare Announces July 2025 Dividend of C$0.042 per Share
-
Intrado's ECaTS Improves PSAP Efficiency and Planning
-
Aptean's Food and Beverage Partner Network Drives Record ERP Growth; Sparking Global Expansion of Partner Program
-
Dayforce Research: Taming Friction Key to Simplifying Workplace Complexity
-
Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide
-
Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025
-
GoodSAM Foods Hires Thrive Market Veteran James Ren as Vice President of Revenue and Growth to Scale and Advance Mission of Food System Transformation
-
Allarity Therapeutics Announces New Licensing and Laboratory Services Agreement to Expand DRP® Platform Utilization
-
Etex strengthens Latin American presence with EUR 65 million investments in plasterboard production
-
Southern Sky Home Buyers Publishes New Article on ‘The Best Way to Sell Your House Fast In Knoxville: The Benefits of Cash Home Buyers’
-
A State Department of Transportation (DOT) Has Entered Into A Formal Contractual Agreement To Evaluate ProStar’s PointMan
-
AI Changes Ripple's XRP Mining, PFMCrypto Launches AI-Enhanced XRP Cloud Mining with Daily Rewards
-
Polyrizon Retains Nasdaq Listing Following Hearings Panel
-
Lori Murphy Appointed as First Board Member of GoodBrand Impact
-
IRS Commissioner Billy Long to Address Tax Professionals at Tax Summit in Salt Lake City
-
Landstar to Release Second Quarter Results on Tuesday, July 29, 2025
-
BSTR Miner Cloud Mining Unveils Industry-First XRP Mining Service: Zero-Hardware Cloud Solution to Earn Ripple Network Rewards
-
Neo Pepe Coin ($NEOP) Announces Massive Giveaway, Rewarding Early Community Members
-
SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study
-
Sky Quarry Announces Strategic Digital Asset Initiative
-
Hengrui Pharma and Kailera Therapeutics Report Positive Topline Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531
-
Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer
-
Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025
-
Neuronetics Appoints New Chief Financial Officer
-
Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQ™ in Patients with Leptomeningeal Metastases
-
WestKam Gold Corp. Provides Update on Management Cease Trade Order, Announces Appointment of Interim CFO and Announces Private Placement
-
ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
-
BriaCell Adds Mayo Clinic to Phase 3 Study in Metastatic Breast Cancer
-
ZEVASKYN™ Gene Therapy Now Available at New Qualified Treatment Center in San Francisco Bay Area
-
Nexxen Expected to Expand its CTV OEM Relationships and ACR Data Reach in Europe Through Vestel’s Strategic Partnership with VIDAA
-
Maryland Supreme Court Affirms MSP Recovery’s Assignments, Paving the Way for Class Action Lawsuit Against GEICO
-
Aurora Spine Announces Participation in 7th Annual American Society of Pain & Neuroscience Conference
